The Ad Hoc Group for Medical Research Recommends NIH Funding Levels
ASM and the members of the Ad Hoc Group for Medical Research, which represents patient groups, scientific societies, research institutions, health professionals, educators, and industry, are extremely grateful to Congress for making meaningful, reliable funding support for the National Institutes of Health (NIH) a key national priority. These investments in the NIH yield compound dividends in the form of improved health and quality of life for Americans, young and old.
For FY 2020, the Ad Hoc Group recommends an appropriation of at least $41.6 billion for the NIH, a $2.5 billion increase over the NIH’s program level funding in FY 2019. This funding level would allow for meaningful growth above inflation in the base budget that would expand NIH’s capacity to support promising science in all disciplines. It also would ensure that funding from the Innovation Account established in the 21st Century Cures Act would supplement the agency’s base budget, as intended, through dedicated funding for specific programs.
For FY 2020, the Ad Hoc Group recommends an appropriation of at least $41.6 billion for the NIH, a $2.5 billion increase over the NIH’s program level funding in FY 2019. This funding level would allow for meaningful growth above inflation in the base budget that would expand NIH’s capacity to support promising science in all disciplines. It also would ensure that funding from the Innovation Account established in the 21st Century Cures Act would supplement the agency’s base budget, as intended, through dedicated funding for specific programs.
